Skip to content
Menu
Breaking Efficacy Ceilings
Home
About
Science
Pipeline
News
Careers
Triveni Bio
News
The latest company updates, news, and insights
Triveni Doses First Subject in Global Phase 2 Proof of Concept Study of TRIV-509 in Atopic Dermatitis, Presents Translational Data at 2025 EADV Congress Demonstrating Novel Biology in Patient Samples
Press Release
9.23.2025
Fierce Biotech names Triveni Bio a “Fierce 15” Biotech Company of 2025
Press Release
9.22.2025
Top
